ArticleJournal of pharmaceutical policy and practice2024

Real-world effectiveness of aromatase inhibitors and fulvestrant in HR+/HER2- advanced breast cancer: a snapshot of the last two years before conventional use of CDK 4/6 inhibitors in a Portuguese institution.

Maria Inês Teodoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.